S&P 500   5,062.56 (+1.62%)
DOW   38,883.30 (+0.70%)
QQQ   435.61 (+2.35%)
AAPL   182.97 (+0.36%)
MSFT   411.27 (+2.26%)
META   485.56 (+3.75%)
GOOGL   144.23 (+1.18%)
AMZN   172.54 (+2.34%)
TSLA   193.06 (-0.88%)
NVDA   777.30 (+15.20%)
NIO   5.74 (-3.85%)
AMD   180.03 (+9.58%)
BABA   75.54 (-0.05%)
T   16.62 (-2.24%)
F   12.21 (+0.58%)
MU   85.42 (+4.82%)
CGC   3.44 (+0.00%)
GE   151.22 (+1.44%)
DIS   108.01 (+0.32%)
AMC   4.54 (-0.66%)
PFE   27.23 (-1.59%)
PYPL   57.59 (+0.19%)
XOM   104.44 (-0.39%)
S&P 500   5,062.56 (+1.62%)
DOW   38,883.30 (+0.70%)
QQQ   435.61 (+2.35%)
AAPL   182.97 (+0.36%)
MSFT   411.27 (+2.26%)
META   485.56 (+3.75%)
GOOGL   144.23 (+1.18%)
AMZN   172.54 (+2.34%)
TSLA   193.06 (-0.88%)
NVDA   777.30 (+15.20%)
NIO   5.74 (-3.85%)
AMD   180.03 (+9.58%)
BABA   75.54 (-0.05%)
T   16.62 (-2.24%)
F   12.21 (+0.58%)
MU   85.42 (+4.82%)
CGC   3.44 (+0.00%)
GE   151.22 (+1.44%)
DIS   108.01 (+0.32%)
AMC   4.54 (-0.66%)
PFE   27.23 (-1.59%)
PYPL   57.59 (+0.19%)
XOM   104.44 (-0.39%)
S&P 500   5,062.56 (+1.62%)
DOW   38,883.30 (+0.70%)
QQQ   435.61 (+2.35%)
AAPL   182.97 (+0.36%)
MSFT   411.27 (+2.26%)
META   485.56 (+3.75%)
GOOGL   144.23 (+1.18%)
AMZN   172.54 (+2.34%)
TSLA   193.06 (-0.88%)
NVDA   777.30 (+15.20%)
NIO   5.74 (-3.85%)
AMD   180.03 (+9.58%)
BABA   75.54 (-0.05%)
T   16.62 (-2.24%)
F   12.21 (+0.58%)
MU   85.42 (+4.82%)
CGC   3.44 (+0.00%)
GE   151.22 (+1.44%)
DIS   108.01 (+0.32%)
AMC   4.54 (-0.66%)
PFE   27.23 (-1.59%)
PYPL   57.59 (+0.19%)
XOM   104.44 (-0.39%)
S&P 500   5,062.56 (+1.62%)
DOW   38,883.30 (+0.70%)
QQQ   435.61 (+2.35%)
AAPL   182.97 (+0.36%)
MSFT   411.27 (+2.26%)
META   485.56 (+3.75%)
GOOGL   144.23 (+1.18%)
AMZN   172.54 (+2.34%)
TSLA   193.06 (-0.88%)
NVDA   777.30 (+15.20%)
NIO   5.74 (-3.85%)
AMD   180.03 (+9.58%)
BABA   75.54 (-0.05%)
T   16.62 (-2.24%)
F   12.21 (+0.58%)
MU   85.42 (+4.82%)
CGC   3.44 (+0.00%)
GE   151.22 (+1.44%)
DIS   108.01 (+0.32%)
AMC   4.54 (-0.66%)
PFE   27.23 (-1.59%)
PYPL   57.59 (+0.19%)
XOM   104.44 (-0.39%)

Immatics (IMTXW) Competitors

$3.57
+0.23 (+6.89%)
(As of 02/21/2024 ET)

IMTXW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW

Should you be buying Immatics stock or one of its competitors? The main competitors of Immatics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.

Immatics vs.

180 Life Sciences (NASDAQ:ATNFW) and Immatics (NASDAQ:IMTXW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, community ranking, dividends and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Immatics$75.72MN/AN/AN/AN/A

180 Life Sciences and Immatics both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
ImmaticsN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Immatics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Immatics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Immatics Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Immatics N/A N/A N/A

Summary

Immatics beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.


Get Immatics News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMTXW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IMTXW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IMTXW vs. The Competition

MetricImmaticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$586.16M$5.11B$7.50B
Dividend YieldN/A3.47%2.91%3.86%
P/E RatioN/A253.4290.3614.33
Price / SalesN/A23,123.602,865.2760.26
Price / CashN/A11.3489.1453.30
Price / BookN/A5.964.314.62
Net IncomeN/A-$22.28M$112.35M$207.21M
7 Day Performance19.00%1.41%1.05%-0.39%
1 Month Performance2.00%2.88%6.45%3.85%
1 Year Performance63.76%66.95%8.05%4.27%

Immatics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-83.1%$0.00N/A0.005Positive News
Gap Up
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.03
flat
N/AN/A$0.00$90,718.000.002Positive News
Gap Down
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.28
flat
N/A-37.5%$0.00N/A0.0094Positive News
Gap Up
APLMW
Apollomics
0 of 5 stars
$0.02
-32.1%
N/AN/A$0.00N/A0.0059Gap Down
ARTLW
Artelo Biosciences
0 of 5 stars
$0.02
flat
N/AN/A$0.00N/A0.005Negative News
BCDAW
BioCardia
0 of 5 stars
$0.02
+94.3%
N/A-97.3%$0.00$570,000.000.0030Positive News
Gap Down
High Trading Volume
BCTXW
BriaCell Therapeutics
0 of 5 stars
$1.29
+7.5%
N/A-47.5%$0.00N/A0.0016Gap Down
CDIOW
Cardio Diagnostics
0 of 5 stars
$0.12
flat
N/A+64.9%$0.00$12,705.000.007Positive News
Gap Down
CTCXW
Carmell
0 of 5 stars
$0.19
flat
N/AN/A$0.00$3.73M0.009Positive News
SAVAW
Cassava Sciences
0 of 5 stars
$7.20
+4.8%
N/AN/A$0.00N/A0.0026Gap Down

Related Companies and Tools

This page (NASDAQ:IMTXW) was last updated on 2/22/2024 by MarketBeat.com Staff